Nearly a quarter of the $404 billion total is for “indirect costs” –
things such as not showing up to work because of diabetes, diminished
productivity, inability to work due to disability, and lost economic
contributions compared with adults who don’t have diabetes or prediabetes.
And whether you have diabetes or not, you’re paying a price. We all
are. In fact, diabetes cost every American $1,240 in 2017.
Now you’re probably wondering: Will these costs continue to rise?
According to the Diabetes
2030 study, yes – up to $622 billion in a little more than the
next ten years. But fewer new cases of diabetes could contribute to
reduced costs, as could more and improved efforts to educate people
with diabetes in better self-care.
Like our approach to help people with diabetes better afford their
medicines, collaboration at national, state, and city levels will be
key in lowering the economic burden of diabetes in the U.S. For example: